FindTrial
Sign In

A Study On Kirubha Kadatcha Dhiravagam And Venpadai Lebam For The Treatment Of Vitiligo In Children

A Single Arm Open Clinical Trial To Evaluate The Effect OF Kirubha Kadatcha Dhiravagam (Internal medicine) And Venpadai Lebam (External medicine) In The Management Of Venpadai(Vitiligo) In Children - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086979
Enrollment
40
Registered
2025-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: KIRUBHA KADATCHA DHIRAVAGAM(Internal medicine) and VENPADAI LEBAM(External medicine): Should be administrated orally twice a day after food. Dosage 1-20 drop according to age of patient

Sponsors

Dr V Sandhiya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: skin with depigmented patches presence sensation

Exclusion criteria

Exclusion criteria: children below 5 years and above 12 years children with Psoriasis,Albinism,Hannsens diseases and Tinea Versicolor White patches with burns and scalds loss of senstion

Design outcomes

Primary

MeasureTime frame
This stuudy will help to understand the effect of KIRUBHA KADATCHA DHIRAVAGAM and VENPADAI LEBAM in the management of vitiligoTimepoint: This stuudy will help to understand the effect of KIRUBHA KADATCHA DHIRAVAGAM and VENPADAI LEBAM in the management of vitiligo Within 48 Days—

Secondary

MeasureTime frame
This study will help to the management of vitiligoTimepoint: This study will help to the management of vitiligo within 48 days—

Countries

India

Contacts

Public ContactDr K Shyamala

Government Siddha Medical College & Hospital, Palayamkottai,Tirunelveli

Shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026